Innovate Biopharma (INNT) Announces R&D Collaboration with Maryland University Schoo of Medicine on …

Innovate Biopharma (INNT) Announces R&D Collaboration with Maryland University Schoo of Medicine on …

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Innovate Biopharmaceuticals Inc. (NASDAQ: INNT) announced today it has agreed to collaborate with Professor O. Colin Stine, Ph.D., at the University of Maryland School of Medicine, whose research is focused on the study of molecular mechanism of bacterial invasion of the intestinal […]

Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing

Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing

Nutra Pharma is announcing the execution of a Letter of Intent for a $4 Million financing to fund a joint venture for the marketing and distribution of the Company’s Over-the-Counter products. CORAL SPRINGS, Fla., June 28, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and […]

GBT Eyes Fast Nod for Sickle Cell Drug but Won't Use Patient-Reported Data

GBT Eyes Fast Nod for Sickle Cell Drug but Won't Use Patient-Reported Data

Xconomy San Francisco —  Global Blood Therapeutics hasn’t finished testing its treatment for sickle cell disease, but the South San Francisco, CA-based company thinks it can get a fast-track approval for the once-a-day pill, voxelotor, from the FDA. That was the company’s message this morning when it presented results from the first half of its […]

Video Game Addiction is an Official Mental Health Diagnosis but Treatment is Hard to Find

Video Game Addiction is an Official Mental Health Diagnosis but Treatment is Hard to Find

Please enable Javascript to watch this video DES MOINES, Iowa  —  For years, many health professionals, and parents, have recognized addictive gaming behavior as a serious problem. The World Health Organization now has gaming disorder as an official mental health diagnosis. The World Health Organization said gaming disorder has to do with the amount of […]

Regenerative Medicine Market to be Driven by Rising Incidences of Chronic Diseases and Massive Growth in Geriatric …

Regenerative Medicine Market to be Driven by Rising Incidences of Chronic Diseases and Massive Growth in Geriatric …

Additionally, regenerative medicine is also inclusive of tissue engineering. Bioengineers along with biologists, nanotechnologists, physicians and other specialties are working upon connecting tissues and potential organs or scaffolds made of biological materials to resemble cartilage, bone and other structure that supports tissue and organ growth. Browse 104 page research report with TOC on “Global Regenerative […]

Putting the Declaratory Judgment Cart Before the Hatch-Waxman Horse

Putting the Declaratory Judgment Cart Before the Hatch-Waxman Horse

In a case involving intellectual property, antitrust and constitutional law, the US Court of Appeals for the Federal Circuit upheld dismissal of a declaratory judgment action for failing to meet the immediacy and reality requirements of the Declaratory Judgment Act. Aids Healthcare Foundation, Inc. v. Gilead Sciences, Inc., et al, Case No. 16-2475 (Fed. Cir., May […]

Arsanis, Inc (ASNS) Reports Discontinuation of its Phase 2 Clinical Trial of ASN100 for Prevention of S. aureus …

Arsanis, Inc (ASNS) Reports Discontinuation of its Phase 2 Clinical Trial of ASN100 for Prevention of S. aureus …

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases, today announced the discontinuation of its Phase 2 clinical trial of ASN100 for the prevention […]

Medical cannabis for epilepsy approved in FDA first

Medical cannabis for epilepsy approved in FDA first

Welcome to Medical News Today Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current list) using cookies and similar automatic collection tools in order to a) personalize content and/or offers […]